tacrine has been researched along with Demyelinating Diseases in 2 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, S | 1 |
| Lee, DW | 1 |
| Schachner, M | 1 |
| Park, HC | 1 |
| Amar, K | 1 |
| Wilcock, GK | 1 |
| Scot, M | 1 |
| Lewis, T | 1 |
1 trial available for tacrine and Demyelinating Diseases
| Article | Year |
|---|---|
The presence of leuko-araiosis in patients with Alzheimer's disease predicts poor tolerance to tacrine, but does not discriminate responders from non-responders.
Topics: Alzheimer Disease; Brain; Brain Ischemia; Demyelinating Diseases; Double-Blind Method; Female; Geria | 1997 |
1 other study available for tacrine and Demyelinating Diseases
| Article | Year |
|---|---|
Small compounds mimicking the adhesion molecule L1 improve recovery in a zebrafish demyelination model.
Topics: Animals; Cell Differentiation; Demyelinating Diseases; Disease Models, Animal; Duloxetine Hydrochlor | 2021 |